Mail

UK markets close in 5 hours 39 minutes

FTSE 100
8,117.46
+38.60(+0.48%)
FTSE 250
19,836.03
+234.05(+1.19%)
AIM
755.69
+2.57(+0.34%)
GBP/EUR
1.1657
+0.0001(+0.01%)
GBP/USD
1.2516
+0.0005(+0.04%)
Bitcoin GBP
51,465.32
+452.23(+0.89%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Pharming Group N.V. (0QCO.L)

LSE - LSE Delayed price. Currency in EUR

Add to watchlist

0.8083

+0.0293

(+3.76%)

As of 06:19PM BST. Market open.

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	N/A
Enterprise value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.74
52-week change ³	N/A
S&P500 52-week change ³	21.08%
52-week high ³	0.8095
52-week low ³	0.8000
50-day moving average ³	N/A
200-day moving average ³	N/A

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	638.56M
Implied shares outstanding ⁶	N/A
Float ⁸	657.77M
% held by insiders ¹	2.34%
% held by institutions ¹	19.14%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	N/A
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	0.1:1
Last split date ³	05 Mar 2013

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-4.30%
Operating margin (ttm)	-18.83%

Management effectiveness

Return on assets (ttm)	-3.06%
Return on equity (ttm)	-4.98%

Income statement

Revenue (ttm)	245.32M
Revenue per share (ttm)	0.37
Quarterly revenue growth (yoy)	48.70%
Gross profit (ttm)	N/A
EBITDA	-15.29M
Net income avi to common (ttm)	-10.55M
Diluted EPS (ttm)	0.0150
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	213.42M
Total cash per share (mrq)	0.32
Total debt (mrq)	171.54M
Total debt/equity (mrq)	78.41%
Current ratio (mrq)	4.06
Book value per share (mrq)	0.33

Cash flow statement

Operating cash flow (ttm)	-17.3M
Levered free cash flow (ttm)	8.06M